Posts by: Diana Campelo Delgado

Researchers have found a molecular link between Parkinson’s disease and melanoma, a type of skin cancer, in the form of protein clumps. Their study results were presented at the spring ... Read more

April 12, 2021April 12, 2021

FDA Committee Seeks Feedback on Avacopan Ahead of Public Meeting

ANCA Vasculitis News

A committee of the U.S. Food and Drug Administration (FDA) is holding a public meeting to discuss the potential approval of avacopan for the treatment of ANCA-associated vasculitis (AAV). During ... Read more

April 9, 2021April 9, 2021

Health Canada Allows Start of DA01 Trial Testing Cell Therapy

Parkinson's News Today

BlueRock Therapeutics has received permission from Health Canada to start a Phase 1 clinical trial evaluating DA01, an investigational cell therapy that aims to restore neurons lost to Parkinson’s disease. ... Read more

April 9, 2021April 9, 2021

Phase 2 Trial of Cognitive Treatment NYX-458 Resumes

COVID-19 News, Parkinson's News Today

Aptinyx‘s Phase 2 clinical trial evaluating its investigational oral compound NYX-458 for the treatment of cognitive impairment and mild dementia associated with Parkinson’s disease is resuming patient screening after a temporary ... Read more

April 2, 2021April 2, 2021

New Study Seeks to Track ALS Progression With Smartphone App

ALS News Today, COVID-19 News

The Muscular Dystrophy Association (MDA) is urging people with amyotrophic lateral sclerosis (ALS) to take part in a new study that’s seeking to track disease progression through a mobile app. ... Read more

April 2, 2021April 2, 2021

Magnetic Nanoparticles May Help Restore Brain Function

Parkinson's News Today

Magnetic nanoparticles may help restore brain function by directing nerve cell growth, a new study shows. Researchers believe this technology has therapeutic potential and may be used in the development of ... Read more

April 2, 2021April 2, 2021

One Walk/Run ‘Shuttle Test’ Captures Exercise Capacity in CF Children, Study Says

Cystic Fibrosis News Today

Disease progression and the overall health of young people with cystic fibrosis (CF) can be evaluated by putting them through the modified shuttle test (MST) once, as ... Read more

April 2, 2021April 2, 2021

KL-6 Protein Found to Be a Promising Biomarker for IPF Prognosis

Pulmonary Fibrosis News

A protein linked to lung inflammation, known as Krebs von den Lungen-6, or KL-6, was found to be a reliable biomarker for the prognosis of patients with idiopathic pulmonary fibrosis ... Read more

April 1, 2021April 2, 2021

Long-term Pulmonary Rehabilitation Can Benefit COPD Patients in Real Life

COPD News Today

Long-term pulmonary rehabilitation (PR) maintenance programs can benefit people with chronic obstructive pulmonary disease (COPD) in a real-life setting, a retrospective study indicates. In fact, PR maintenance programs lasting three ... Read more

April 1, 2021April 1, 2021

ALS Groups Give $1.1M More in Support of T-cell Therapy in Phase 2 Trial

ALS News Today

The ALS Association, Muscular Dystrophy Association (MDA), and ALS Finding a Cure have given an additional $1.1 million to support work on a cell therapy — now in a Phase 2 ... Read more

March 31, 2021March 31, 2021

Ofev’s Ability to Slow Decline in Progressing ILDs Not Dependent on Prior Therapy

Pulmonary Fibrosis News

The ability of Ofev (nintedanib) to improve lung function in people with progressive fibrosing interstitial lung diseases (ILDs) is not influenced by their use of immunomodulatory therapies, a study indicates. ... Read more

March 31, 2021March 31, 2021

Life Edit Will Use CFF Award to Explore Gene-editing Technology

Cystic Fibrosis News Today

The Cystic Fibrosis Foundation (CFF) is awarding Life Edit Therapeutics up to $400,000 to explore its new gene-editing technology to develop treatments for certain patients with cystic fibrosis (CF) who cannot ... Read more

March 30, 2021March 30, 2021

Imara Opens Higher Dose Arms in Phase 2b Trials of IMR-687

Sickle Cell Disease News

Imara is opening higher dose arms in two Phase 2b trials assessing the safety and efficacy of IMR-687, its potential therapy for sickle cell disease (SCD) and beta-thalassemia, in patients ... Read more

March 30, 2021March 30, 2021

Protein Fragment in CSF Shows Potential as Diagnostic Biomarker

Parkinson's News Today

A protein fragment known as GPR37 is evident in the cerebrospinal fluid of people with Parkinson’s disease, and may be promising candidate as a biomarker for earlier diagnosis, scientists in Spain ... Read more

March 30, 2021March 30, 2021

IPF Diagnosis and Treatment Changing for Better in UK, Registry Study Finds

Pulmonary Fibrosis News

Changes for the better in diagnosing idiopathic pulmonary fibrosis (IPF) and managing patients in the U.K. are evident in recent years, a real-world study based on registry data indicates. “Patient registries offer ... Read more